News About: Pharm. Industry
Domestic hyperlipidemia drug market in transition
The local hyperlipidemia drug market is undergoing a major transformation as Janssen’s Crestor (rosuvastatin)is likely to overtake Pfizer’s Lipitor (atorvastatin) in sales, reshuffling the leader board of a popular dr...
What’s on Teva’s mind?
Shares of the mid-tier pharmaceutical firms has been in steep rally, since a health ministry official said that generic drug giant Teva enters into an agreement with a Korean firm over possible merger.
So far, seve...
Janssen Korea’s associate wholesaler goes belly-up
Janssen Korea’ associate wholesaler located at Daerim-dong in Seoul went bankrupt amid spreading rumors that the bankruptcy is closely associated with a mutual agreement expired last month, market sources said on Octo...
Innovative drug firms are under probe over illegal kickbacks
The nation’s 43 innovative drug firms are under screening process over their history of illegal rebate, according to market sources.
The Ministry of Health and Welfare Monday delivered a circular letter to those su...
Daehan New Pharm to supply 60 billion won protein A
Daehan New Pharm said Monday that has established a a marketing and distribution partnership with the U.S. based GenScript and Japan based Pharmawin to supply protein A worth 60 billion won.
The capacity of protein...
Teva’s merger is still in fog
There are spreading rumors that Israel generic giant Teva would acquire majority stocks of a Korean mid-sized pharmaceutical firm worth 100 billion won, but the details are yet unidentified.
Several companies, incl...
Celltrion opens world-first biosimilar symposium
Celltrion, a local biopharmaceutical company, said Friday it held a launching symposium for its world’s first antibody biosimilar ‘Remsima’ at Millennium Hilton Hotel in Seoul.
Remsima is a biosimilar version of U....
Myungmoon denies Teva’s takeover
Myungmoon Pharm Thursday dismissed the report of M&A (merger and acquisition) with Israel’s generic giant Teva Pharmaceutical Industries.
Ahn Do-gul, a ministry official of Health and Welfare, said Wednesday that T...
Myungmoon shares showing steep rally
Myungmoon Pharm’s shares showed steep rally Wednesday and Thursday following the report that Israel’s generic giant Teva Pharmaceutical Industries would acquire a controlling in the Korean firm.
Alvogen has recentl...
37 drug makers spend 10% of revenue in 2011
Korea’s 37 pharmaceutical firms spared 9.6 percent of their annual revenue on research and development (R&D) of new medicine last year, up 12.1 percent from a year earlier, a poll showed Thursday.
A survey released...
